Key result
Amiloride suppresses inducible ventricular tachyarrhythmias in 50% of postinfarction dogs versus placebo.
Why the study?
Amiloride has multiple cardiac pharmacological actions, including prolonging action potential duration, but its antiarrhythmic efficacy in postinfarction inducible sustained ventricular tachyarrhythmias required assessment.
Does amiloride prevent inducible sustained ventricular tachyarrhythmias in a canine postinfarction model?
RCT (n=16)
Randomly assigned
Does amiloride prevent inducible sustained ventricular tachyarrhythmias in a canine postinfarction model?
Amiloride demonstrates antiarrhythmic activity by suppressing sustained ventricular tachyarrhythmias in a canine postinfarction model, primarily by prolonging border zone ventricular refractoriness.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Duff et al. reported that amiloride suppressed sustained VT evoked by 2-hr ischemia and reperfusion of the left anterior descending artery of the dog in half of the treated dogs, and the responding dogs had smaller infarct size compared to dogs not responding to amiloride.”
Amiloride may suppress post-MI ventricular tachyarrhythmias in dogs; hypothesis-generating for human translation.
Amiloride, a widely used diuretic, has multiple pharmacological actions, including inhibition of the sodium-hydronium ion and the sodium-calcium exchanger in heart. In terms of cardiac electrophysiology, amiloride prolongs action potential duration without alteration in upstroke velocity of phase 0 in Purkinje fibers. The antiarrhythmic efficacy of amiloride was assessed in a model of inducible sustained ventricular tachyarrhythmias in 16 dogs late after 2-hour occlusion-reperfusion of the left anterior descending coronary artery. Sixteen animals were studied: Four were randomly assigned to placebo, and 12 were assigned to amiloride treatment. Prolonged loading and maintenance infusions were designed to produce amiloride concentrations over the range achievable in humans. Animals were chronically instrumented to allow electrophysiological measures of conduction and refractoriness in the left ventricular infarct and border zones. Of the 12 animals treated with amiloride, six responded with inability to induce ventricular tachyarrhythmias, whereas of the four animals treated with placebo, none responded. The mean infarct size of the six animals responding to amiloride (12 +/- 5%) was significantly less than that of the six animals not responding to amiloride (20 +/- 8%). Overall, the only electrophysiological effect of amiloride observed in this study was prolongation of border zone ventricular refractoriness. This electrophysiological effect was accentuated in animals responding to amiloride. In addition, when animals were subdivided into responders, partial responders, or nonresponders, the border zone repolarization time was prolonged in responders and partial responders, whereas this measure shortened in nonresponding animals. Amiloride has antiarrhythmic activity in the suppression of sustained ventricular tachyarrhythmias in this postinfarction model.
No takes yet. Share an insight, caveat, or question.
Duff et al. (1988) conducted an RCT in Inducible sustained ventricular tachyarrhythmias (n=16). Amiloride vs. Placebo was evaluated on Inability to induce ventricular tachyarrhythmias. Amiloride suppressed inducible sustained ventricular tachyarrhythmias in 50% of treated dogs compared to 0% of those receiving placebo in a postinfarction model.
Synapse has enriched 10 related papers. Consider them for comparative context: